Copyright
©The Author(s) 2021.
World J Gastrointest Pathophysiol. May 22, 2021; 12(3): 40-50
Published online May 22, 2021. doi: 10.4291/wjgp.v12.i3.40
Published online May 22, 2021. doi: 10.4291/wjgp.v12.i3.40
Table 1 Baseline demographics
| Training (n = 715) | Validation (n = 312) | P value | |
| Age (yr) | 45.6 (10.7) | 44.5 (11.1) | 0.1 |
| Male/female (%) | 66/34 | 66/34 | 1.0 |
| Platelets (× 109/L) | 186.7 (64.4) | 190.6 (68.2) | 0.4 |
| Alanine aminotransferase (IU/L) | 103.8 (88.1) | 105.1 (89.1) | 0.8 |
| Aspartate aminotransferase (IU/L) | 69.9 (55.0) | 68.0 (53.3) | 0.6 |
| Albumin (g/dL) | 3.9 (0.46) | 3.9 (0.39) | 0.2 |
| Alkaline phosphatase (IU/L) | 82.3 (39.2) | 79.0 (29.2) | 0.1 |
| Prothrombin time (s) | 13.0 (1.3) | 12.9 (1.1) | 0.3 |
| Total bilirubin (mg/dL) | 0.81 (0.48) | 0.77 (0.45) | 0.2 |
| Ishak fibrosis | 2.4 (1.8) | 2.3 (1.7) | 0.3 |
| HAI inflammation | 8.0 (3.0) | 7.9 (3.1) | 0.5 |
| HBV/HCV/HDV (%) | 23/68/8 | 23/68/9 | 1.0 |
- Citation: Surana P, Hercun J, Takyar V, Kleiner DE, Heller T, Koh C. Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis. World J Gastrointest Pathophysiol 2021; 12(3): 40-50
- URL: https://www.wjgnet.com/2150-5330/full/v12/i3/40.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v12.i3.40